An analysis of the role of AHR in HER2-overexpressing BC cells by performing ATAC-seq using HER2-5 and HER2-5/AHRKO cells suggested that HER2-activated AHR upregulates the expression of genes annotated as “pathways in cancers” (Figure 1D). This evidence concerns the gene ERBB2 and cancer.